表紙
市場調查報告書

多重診斷的全球市場:2020年∼2024年

Multiplexed Diagnostics Market by End-user and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 315306
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
Back to Top
多重診斷的全球市場:2020年∼2024年 Multiplexed Diagnostics Market by End-user and Geography - Forecast and Analysis 2020-2024
出版日期: 2020年02月07日內容資訊: 英文 120 Pages
簡介

全球多重診斷市場在2020年∼2024年的預測期間內,預計將以15%的年複合成長率增長,達到93億5,000萬美元的規模。慢性疾病及感染疾病的流行等促進了市場的成長。此外,技術進步有望推動市場增長。

本報告提供全球多重診斷市場相關調查分析,提供市場規模及成長率,市場趨勢,推動市場要素,課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 市場的狀況

  • 市場生態系統
  • 市場特徵

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模(2019年)
  • 市場展望:預測(2019年∼2024年)

第4章 波特的五力分析

  • 波特五力分析摘要
  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 對手的威脅
  • 市場情況

第5章 市場區隔:各終端用戶

  • 市場區隔
  • 比較:各終端用戶的配置
  • 製藥·生物科技企業-市場規模與預測2019-2024
  • 醫療保健中心-市場規模與預測2019年-2024
  • 學術機構和CRO-市場規模與預測2019-2024
  • 市場機會:各終端用戶

第6章 客戶形勢

  • 概要

第7章 各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美-市場規模與預測2019-2024
  • 歐洲-市場規模與預測2019-2024
  • 亞太地區-市場規模與預測2019-2024
  • 南美-市場規模與預測2019-2024
  • 中東·非洲地區-市場規模與預測2019-2024
  • 主要國家
  • 市場機會:各地理學

第8章 成長要素,課題,及趨勢

  • 數量的成長要素-需求主導型成長
  • 數量的成長要素-外部要素
  • 市場課題
  • 市場趨勢

第9章 供應商的展望

  • 業者情勢
  • 形勢的創新

第10章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Agilent Technologies Inc.
  • Becton, Dickinson and Co.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • Merck KGaA
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

第11章 附錄

  • 調查範圍
  • 美金的貨幣換算比率
  • 調查方法
  • 簡稱的清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR40652

Technavio has been monitoring the global multiplexed diagnostics market and it is poised to grow by USD 9.35 bn during 2020-2024, progressing at a CAGR of 15% during the forecast period. Our reports on global multiplexed diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by prevalence of chronic and infectious diseases.

In addition, technological advancements is anticipated to boost the growth of the global multiplexed diagnostics market as well.

Market Segmentation

Technavio's global multiplexed diagnostics market is segmented as below:

end-user

  • pharmaceutical and biotechnology companies
  • healthcare centers
  • academic institutes and CROs

Geographic segmentation

  • APAC
  • Europe
  • MEA
  • North America
  • South America

Key Trends for global multiplexed diagnostics market growth

This study identifies technological advancements as the prime reasons driving the global multiplexed diagnostics market growth during the next few years.

Prominent vendors in global multiplexed diagnostics market

We provide a detailed analysis of around 25 vendors operating in the global multiplexed diagnostics market, including some of the vendors such as Agilent Technologies Inc., Becton, Dickinson and Co., bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Merck KGaA, QIAGEN NV, F. Hoffmann-La Roche Ltd., Siemens AG and Thermo Fisher Scientific Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End user placement
  • Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024
  • Healthcare centers - Market size and forecast 2019-2024
  • Academic institutes and CROs - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • Becton, Dickinson and Co.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • Merck KGaA
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 4
  • 5.Key Finding 5
  • 6.Key Finding 6
  • 7.Key Finding 7
  • 8.Market in focus
  • 9.Parent market
  • 10.Market characteristics
  • 11.Product / Service portfolio of key vendors included in the market definition
  • 12.Market segments
  • 13.Global - Market size and forecast 2019 - 2024 ($ million)
  • 14.Global market: Year-over-year growth 2019 - 2024 (%)
  • 15.Five forces analysis 2019 & 2024
  • 16.Bargaining power of buyers
  • 17.Bargaining power of suppliers
  • 18.Threat of new entrants
  • 19.Threat of substitutes
  • 20.Threat of rivalry
  • 21.Market condition - Five forces 2019
  • 22.End user placement - Market share 2019-2024 (%)
  • 23.Comparison by End user placement
  • 24.Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024 ($ million)
  • 25.Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2024 (%)
  • 26.Healthcare centers - Market size and forecast 2019-2024 ($ million)
  • 27.Healthcare centers - Year-over-year growth 2019-2024 (%)
  • 28.Academic institutes and CROs - Market size and forecast 2019-2024 ($ million)
  • 29.Academic institutes and CROs - Year-over-year growth 2019-2024 (%)
  • 30. Market opportunity by End user
  • 31.Customer landscape
  • 32.Market share by geography 2019-2024 (%)
  • 33.Geographic comparison
  • 34.North America - Market size and forecast 2019-2024 ($ million)
  • 35.North America - Year-over-year growth 2019-2024 (%)
  • 36.Europe - Market size and forecast 2019-2024 ($ million)
  • 37.Europe - Year-over-year growth 2019-2024 (%)
  • 38.APAC - Market size and forecast 2019-2024 ($ million)
  • 39.APAC - Year-over-year growth 2019-2024 (%)
  • 40.South America - Market size and forecast 2019-2024 ($ million)
  • 41.South America - Year-over-year growth 2019-2024 (%)
  • 42.MEA - Market size and forecast 2019-2024 ($ million)
  • 43.MEA - Year-over-year growth 2019-2024 (%)
  • 44.Key leading countries
  • 45.Market opportunity by geography ($ million)
  • 46.Impact of drivers
  • 47.Impact of challenges
  • 48.Landscape disruption
  • 49.Industry risks
  • 50.Vendors covered
  • 51.Market positioning of vendors
  • 52.Agilent Technologies Inc. - Overview (1/3)
  • 53.Agilent Technologies Inc. - Overview (2/3)
  • 54.Agilent Technologies Inc. - Overview (3/3)
  • 55.Agilent Technologies Inc. - Business segments
  • 56.Agilent Technologies Inc. - Key offerings
  • 57.Agilent Technologies Inc. - Key customers
  • 58.Agilent Technologies Inc. - Segment focus
  • 59.Becton, Dickinson and Co. - Overview (1/3)
  • 60.Becton, Dickinson and Co. - Overview (2/3)
  • 61.Becton, Dickinson and Co. - Overview (3/3)
  • 62.Becton, Dickinson and Co. - Business segments
  • 63.Becton, Dickinson and Co. - Key offerings
  • 64.Becton, Dickinson and Co. - Key customers
  • 65.Becton, Dickinson and Co. - Segment focus
  • 66.bioMerieux SA - Overview (1/3)
  • 67.bioMerieux SA - Overview (2/3)
  • 68.bioMerieux SA - Overview (3/3)
  • 69.bioMerieux SA - Business segments
  • 70.bioMerieux SA - Key offerings
  • 71.bioMerieux SA - Key customers
  • 72.bioMerieux SA - Segment focus
  • 73.Bio-Rad Laboratories Inc. - Overview (1/3)
  • 74.Bio-Rad Laboratories Inc. - Overview (2/3)
  • 75.Bio-Rad Laboratories Inc. - Overview (3/3)
  • 76.Bio-Rad Laboratories Inc. - Business segments
  • 77.Bio-Rad Laboratories Inc. - Key offerings
  • 78.Bio-Rad Laboratories Inc. - Key customers
  • 79.Bio-Rad Laboratories Inc. - Segment focus
  • 80.Illumina Inc. - Overview (1/3)
  • 81.Illumina Inc. - Overview (2/3)
  • 82.Illumina Inc. - Overview (3/3)
  • 83.Illumina Inc. - Business segments
  • 84.Illumina Inc. - Key offerings
  • 85.Illumina Inc. - Key customers
  • 86.Illumina Inc. - Segment focus
  • 87.Merck KGaA - Overview (1/3)
  • 88.Merck KGaA - Overview (2/3)
  • 89.Merck KGaA - Overview (3/3)
  • 90.Merck KGaA - Business segments
  • 91.Merck KGaA - Key offerings
  • 92.Merck KGaA - Key customers
  • 93.Merck KGaA - Segment focus
  • 94.QIAGEN NV - Overview (1/3)
  • 95.QIAGEN NV - Overview (2/3)
  • 96.QIAGEN NV - Overview (3/3)
  • 97.QIAGEN NV - Business segments
  • 98.QIAGEN NV - Key offerings
  • 99.QIAGEN NV - Key customers
  • 100.QIAGEN NV - Segment focus
  • 101.F. Hoffmann-La Roche Ltd. - Overview (1/3)
  • 102.F. Hoffmann-La Roche Ltd. - Overview (2/3)
  • 103.F. Hoffmann-La Roche Ltd. - Overview (3/3)
  • 104.F. Hoffmann-La Roche Ltd. - Business segments
  • 105.F. Hoffmann-La Roche Ltd. - Key offerings
  • 106.F. Hoffmann-La Roche Ltd. - Key customers
  • 107.F. Hoffmann-La Roche Ltd. - Segment focus
  • 108.Siemens AG - Overview (1/3)
  • 109.Siemens AG - Overview (2/3)
  • 110.Siemens AG - Overview (3/3)
  • 111.Siemens AG - Business segments
  • 112.Siemens AG - Key offerings
  • 113.Siemens AG - Key customers
  • 114.Siemens AG - Segment focus
  • 115.Thermo Fisher Scientific Inc. - Overview (1/3)
  • 116.Thermo Fisher Scientific Inc. - Overview (2/3)
  • 117.Thermo Fisher Scientific Inc. - Overview (3/3)
  • 118.Thermo Fisher Scientific Inc. - Business segments
  • 119.Thermo Fisher Scientific Inc. - Key offerings
  • 120.Thermo Fisher Scientific Inc. - Key customers
  • 121.Thermo Fisher Scientific Inc. - Segment focus
  • 122.Currency conversion rates for US$
  • 123.Research Methodology
  • 124.Validation techniques employed for market sizing
  • 125.Information sources
  • 126.List of abbreviations
Back to Top